Table 2 Chest CT findings of patients with Covid-19.

From: Proteomics and metabonomics analyses of Covid-19 complications in patients with pulmonary fibrosis

Finding

All patients

Nonpulmonary fibrosis

Pulmonary fibrosis

Onset (n = 85)

Endpoint (n = 71)

Onset (n = 41)

Endpoint (n = 31)

Onset (n = 44)

Endpoint (n = 40)

No abnormality

11 (12.9)

4 (5.6)

10 (24.4)

4 (12.9)

1 (2.3)

0 (0)

Lesion morphology

 Ground-glass opacities

68 (80)

59 (83.1)

26 (63.4)

20 (64.5)

42 (95.5)

39 (97.5)

 Ground-glass opacities with consolidation

10 (11.8)

3 (4.2)

6 (2.4)

0 (0)

4 (9.1)

3 (7.5)

 Fibrotic stripes

38 (44.7)

40 (56.3)

0 (0)

0 (0)

38 (86.4)

40 (100)

NO. of lobes affected

 0

11 (12.9)

4 (5.6)

10 (24.4)

4 (12.9)

1 (2.3)

0 (0)

 1

15 (17.6)

12 (16.9)

12 (29.3)

9 (29.0)

3 (6.8)

3 (7.5)

 2

7 (8.2)

8 (11.3)

6 (14.6)

5 (16.1)

1 (2.3)

3 (7.5)

 3

10 (11.8)

5 (7.0)

4 (9.8)

2 (6.5)

6 (13.6)

3 (7.5)

 4

3 (3.5)

0 (0)

1 (2.4)

0 (0)

2 (4.5)

0 (0)

 5

38 (44.7)

38 (53.5)

7 (17.1)

7 (22.6)

31 (70.5)

31 (77.5)

Total lung severity score, median (interquartile)

4 (1.5–8.0)

5 (2.0–9.0)

2 (0.5–3.0)

2 (1.0–5.0)

7 (5.0–10.0)

6 (5.0–11.5)

Distribution of lesions

 Peripheral

33 (38.8)

31 (43.7)

17 (41.5)

11 (35.5)

16 (36.4)

20 (50.0)

 Peripheral and central

34 (40.0)

24 (33.8)

7 (17.1)

7 (22.6)

27 (61.4)

17 (42.5)

Other findings

 Linear

50 (58.8)

44 (62.0)

11 (26.8)

9 (29.0)

39 (88.6)

35 (87.5)

 Consolidation

27 (31.8)

18 (25.4)

1 (2.4)

1 (3.2)

26 (59.1)

17 (42.5)

 Discrete pulmonary nodules

15 (17.6)

8 (11.3)

9 (22.0)

5 (16.1)

6 (13.6)

3 (7.5)

 Pulmonary emphysema

14 (16.5)

11 (15.5)

6 (14.6)

5 (16.1)

8 (18.2)

6 (15.0)

 Bronchiectasis

29 (34.1)

27 (38.0)

3 (7.3)

5 (16.1)

26 (59.1)

22 (55.0)

 Pleural effusion

4 (4.7)

2 (2.8)

0 (0)

1 (3.2)

4 (9.1)

1 (2.5)

 Pleural incrassation

43 (50.6)

37 (52.1)

6 (14.6)

5 (16.1)

37 (84.1)

32 (80)

  1. Except where indicated, data are cases of patients, with percentages in parentheses.